<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>CJC-1295: what changed | Grey Peptides</title>
    <link>https://greypeptides.com/changes/#e-cjc-1295</link>
    <atom:link href="https://greypeptides.com/changes/cjc-1295.xml" rel="self" type="application/rss+xml" />
    <description>News, regulatory alerts, corrections and new guides about CJC-1295 on Grey Peptides, newest first.</description>
    <language>en-us</language>
    <lastBuildDate>Wed, 18 Nov 2026 12:00:00 +0000</lastBuildDate>
    <ttl>1440</ttl>
    <item>
      <title>New guide: What lab testing shows</title>
      <link>https://greypeptides.com/testing/#c-cjc-1295</link>
      <guid isPermaLink="false">greypeptides-changes-cjc-1295-guide-/testing/#c-cjc-1295</guid>
      <pubDate>Wed, 18 Nov 2026 12:00:00 +0000</pubDate>
      <category>New guide</category>
      <description>The largest analysis of grey-market test results (a preprint): purity, amount, identity and endotoxin.</description>
    </item>
    <item>
      <title>Regulatory alert: Brazil (ANVISA): Brazil's health regulator said GHK-Cu, BPC-157, TB-500, CJC-1295 and ipamorelin are not registered in any category and are illegal for any health or aesthetic use.</title>
      <link>https://greypeptides.com/regulatory/alerts/#anvisa-peptides-not-registered</link>
      <guid isPermaLink="false">greypeptides-changes-cjc-1295-alert-anvisa-peptides-not-registered</guid>
      <pubDate>Thu, 02 Jul 2026 12:00:00 +0000</pubDate>
      <category>Regulatory alert</category>
      <description>In Brazil an injectable peptide cannot be sold as a supplement or a cosmetic: supplements cannot be injectable and injectable cosmetics do not exist in its rules.</description>
    </item>
  </channel>
</rss>
